News

Last year US Patent office granted another patent (US Patent No 7,544,369) covering Transave Arikace for the sustained release of antibiotic and once-daily treatment of Pseudomonas lung infections.

Salix Pharmaceuticals said that the availability of Xifaxan 550mg occurs in tandem with the launch of Salix’s Hepatic Encephalopathy Living Program (HELP), a patient and health care provider

Daclizumab is a humanised monoclonal antibody that binds to CD25, a receptor subunit that is expressed at low levels on resting T-cells and at high levels on T-cells

Until the clearance, tests for 2009 H1N1 Influenza were only available through an Emergency Use Authorization (EUA), which allows the FDA, based on the evaluation of available data,

Kevetrin is being developed to treat drug resistant cancers. Cellceutix claimed that Kevetrin showed greater tumor growth delay than standard therapies in animal models of resistant lung cancer,

The DAPT Study is a four-year clinical trial investigating the duration of dual antiplatelet therapy (DAPT, the combination of aspirin and a thienopyridine/antiplatelet medication to reduce the risk

The contracts valued at approximately GBP330,000 in total, are for regulatory consultancy and follow on from the first contract for regulatory support signed in January this year. The

The AMEP biotherapy’s original mechanism of action targets specific receptors (integrins) involved in tumor growth and in tumor angiogenesis. Efficacy studies demonstrated that AMEPTM administration in human melanoma

The effect of temperature on liquid chromatography (LC) separations is often crucial where closely eluting substances are being separated and therefore, where accurate data is required, precise temperatures